Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Clinical trial Stories

2014-03-13 17:09:31

'No robust, consistent evidence to show home care visits provide benefit to the elderly' In what's thought to be the biggest review of academic literature into whether home care visits provide benefits for the elderly, researchers conclude there is 'no consistent evidence' to show they lead to the elderly living longer or having more independent lives than those without any visits. Researchers from University College London (UCL) and the University of Oxford analyzed 64 randomized...

Are Your Pets Benefiting From Their Pain Medication?
2014-03-13 15:17:15

Tracey Peake, North Carolina State University How do you know that your pet is benefiting from its pain medication? A new clinical trial design could help overcome pet owners’ unconscious observation bias and determine whether the drugs they test are effective. When animals are recruited for clinical trials, particularly for pain medications, researchers must rely on owner observation to determine whether the medication is working. Sounds simple enough, but as it turns out, human and...

2014-03-13 12:29:30

New Asian Bridging Clinical Research Unit has been opened by Contract Research Organization WCCT Global COSTA MESA, Calif., March 13, 2014 /PRNewswire-iReach/ -- WCCT Global, a full service CRO headquartered in Southern California announced today the opening of a new Asian Bridging clinical research site. This state of the art facility has been reconfigured to provide for 30 semi-private rooms to give each clinical trial volunteer a more comfortable experience for extended in-house...

2014-03-13 08:28:52

Overall Survival Data from the HEAT Study Supports Continued Clinical Development of ThermoDox in Primary Liver Cancer LAWRENCEVILLE, N.J., March 13, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the year ended December 31, 2013, and provided an update on its clinical trials of ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin. ThermoDox is being...

2014-03-12 23:30:50

Salus IRB maintains a legacy of 28 years of continuous service coupled with expanded capabilities. Austin, Texas (PRWEB) March 12, 2014 RCRC IRB announced today that its organization has changed its name to Salus IRB. The management, administrative staff, ownership structure, and review board memberships remain unchanged. “Clinical trials are more complicated, costly, and fast-paced than ever before,” says Salus President Dwight DuBois. “Salus recognizes this changing scientific...

2014-03-12 20:24:11

Conference Call and Webcast on March 13 at 8:30 a.m. EDT BASKING RIDGE, N.J., March 12, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the late-stage, Phase 3 clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced its year-end 2013 corporate highlights and financial results. A conference call and webcast to discuss the results will be held March 13 at 8:30 a.m. EDT. David J....

2014-03-12 16:25:45

HINCKLEY, Ohio, March 12, 2014 /PRNewswire/ -- Clinical Research Management, Inc. (ClinicalRM) - a full-service Contract Research Organization (CRO) providing support for basic and applied research, clinical trials, and regulatory support - announced today it was awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA). With this contract award ClinicalRM becomes part of a clinical studies network being established by BARDA to support development of...

2014-03-12 12:28:22

I'm In campaign to educate underrepresented populations about clinical trial participation WASHINGTON, March 12, 2014 /PRNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) and the National Minority Quality Forum today announced a first-of-its-kind national campaign to help increase diversity in clinical trials. The I'm In campaign will raise awareness about the importance of clinical research and encourage greater participation by diverse patient...

2014-03-12 12:28:20

BETHESDA, Md., March 12, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today refuted false statements and material distortions made by Adam Feuerstein in an article on Tuesday, March 11. http://photos.prnewswire.com/prnvar/20110329/SF73084LOGO Feuerstein falsely accused NW Bio of manipulating its news by delaying announcement of the Hospital Exemption...

2014-03-11 23:33:10

Avail is conducting a Phase 2, randomized, placebo-controlled clinical research study to evaluate the safety and efficacy of an experimental ointment for qualified participants with primary osteoarthritis (OA) affecting a single knee joint. DeLand, FL (PRWEB) March 11, 2014 *To see if you qualify for this Osteoarthritis Clinical Trial in DeLand, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us directly at (386) 785-2404. There is no cost to...